[1]Fam SY, Chee CF, Yong CY, et al. Stealth coating of nanoparticles in drugdelivery systems[J]. Nanomaterials(Basel), 2020, 10(4): 787.
[2]Sheikhpour M, Barani L, Kasaeian A. Biomimetics in drug delivery systems: a critical review[J]. J Control Release, 2017, 253: 97-109.
[3]Sabu C, Rejo C, Kotta S, et al. Bioinspired and biomimetic systems for advanced drug and gene delivery[J]. J Control Release, 2018, 287: 142-155.
[4]Jeanne A, Sarazin T, Charlé M, et al. Towards the therapeutic use of thrombospondin 1/CD47 targeting TAX2 peptide as an antithrombotic agent[J]. Arterioscler Thromb Vasc Biol, 2021, 41(1): e1-e17.
[5]Wang H, Liu Y, He R, et al. Cell membrane biomimetic nanoparticles for inflammation and cancer targeting in drug delivery[J]. Biomater Sci, 2020, 8(2): 552-568.
[6]Roweth HG, Battinelli EM. Lessons to learn from tumoreducated platelets[J]. Blood, 2021, 137(23): 3174-3180.
[7]Liu Y, Zhang Y, Ding Y, et al. Plateletmediated tumor metastasis mechanism and the role of cell adhesion molecules[J]. Crit Rev Oncol Hematol, 2021, 167: 103502.
[8]Le QV, Lee J, Lee H, et al. Cell membranederived vesicles for delivery of therapeutic agents[J]. Acta Pharm Sin B, 2021, 11(8): 2096-2113.
[9]Xu P, Zuo H, Chen B, et al. Doxorubicinloaded platelets as a smart drug delivery system: An improved therapy for lymphoma[J]. Sci Rep, 2017, 7: 42632.
[10]Lazar S, Goldfinger LE. Platelets and extracellular vesicles and their cross talk with cancer[J]. Blood, 2021, 137(23): 3192-3200.
[11]Chi C, Li F, Liu H, et al. Docetaxelloaded biomimetic nanoparticles for targeted lung cancer therapy in vivo[J]. J Nanopart Res, 2019, 21(7): 1-10.
[12]Wang H, Wu J, Williams GR, et al. Plateletmembranebiomimetic nanoparticles for targeted antitumor drug delivery[J]. J Nanobiotechnology, 2019, 17(1): 60.
[13]Li B, Chu T, Wei J, et al. Plateletmembranecoated nanoparticles enable vascular disrupting agent combining antiangiogenic drug for improved tumor vessel impairment[J]. Nano Lett, 2021, 21(6): 2588-2595.
[14]Chen Y, Zhao G, Wang S, et al. Plateletmembranecamouflaged bismuth sulfide nanorods for synergistic radiophotothermal therapy against cancer[J]. Biomater Sci, 2019, 7(8): 3450-3459.
[15]Ding K, Zheng C, Sun L, et al. NIR lightinduced tumor phototherapy using ICG delivery system based on plateletmembranecamouflaged hollow bismuth selenide nanoparticles[J]. Chin Chem Lett, 2020, 31(5): 1168-1172.
[16]Bahmani B, Gong H, Luk BT, et al. Intratumoral immunotherapy using plateletcloaked nanoparticles enhances antitumor immunity in solid tumors[J]. Nat Commun, 2021, 12(1): 1999.
[17]Jiang Q, Wang K, Zhang X, et al. Platelet membranecamouflaged magnetic nanoparticles for ferroptosisenhanced cancer immunotherapy[J]. Small, 2020, 16(22): e2001704.
[18]Zhuang J, Gong H, Zhou J, et al. Targeted gene silencing in vivo by platelet membranecoated metalorganic framework nanoparticles[J]. Sci Adv, 2020, 6(13): eaaz6108.
[19]Wang L, Tang C. Targeting platelet in atherosclerosis plaque formation: current knowledge and future perspectives[J]. Int J Mol Sci, 2020, 21(24): 9760.
[20]Song Y, Huang Z, Liu X, et al. Platelet membranecoated nanoparticlemediated targeting delivery of Rapamycin blocks atherosclerotic plaque development and stabilizes plaque in apolipoprotein Edeficient (ApoE-/-) mice[J]. Nanomedicine, 2019, 15(1): 13-24.
[21]Ma Y, Ma Y, Gao M, et al. Plateletmimicking therapeutic system for noninvasive mitigation of the progression of atherosclerotic plaques[J]. Adv Sci(Weinh), 2021, 8(8): 2004128.
[22]Wang S, Wang R, Meng N, et al. Platelet membranefunctionalized nanoparticles with improved targeting ability and lower hemorrhagic risk for thrombolysis therapy[J]. J Control Release, 2020, 328: 78-86.
[23]Zhao Y, Xie R, Yodsanit N, et al. Hydrogen peroxideresponsive platelet membranecoated nanoparticles for thrombus therapy[J]. Biomater Sci, 2021, 9(7): 2696-2708.
[24]Chouchani ET, Pell VR, James AM, et al. A unifying mechanism for mitochondrial superoxide production during ischemiareperfusion injury[J]. Cell Metab, 2016, 23(2): 254-263.
[25]Tang J, Shen D, Caranasos TG, et al. Therapeutic microparticles functionalized with biomimetic cardiac stem cell membranes and secretome[J]. Nat Commun, 2017, 8: 13724.
[26]Su T, Huang K, Ma H, et al. Plateletinspired nanocells for targeted heart repair after ischemia/reperfusion injury[J]. Adv Funct Mater, 2019, 29(4): 1803567.
[27]Xu L, Chen Y, Jin Q, et al. Biomimetic PLGA microbubbles coated with platelet membranes for early detection of myocardial ischaemiareperfusion injury[J]. Mol Pharm, 2021, 18(8): 2974-2985.
[28]Kim JK, Uchiyama S, Gong H, et al. Engineered biomimetic platelet membranecoated nanoparticles block Staphylococcus aureus cytotoxicity and protect against lethal systemic infection[J]. Engineering, 2021, 7(8): 1149-1156.
[29]EstebanFernández de vila B, Angsantikul P, RamírezHerrera DE, et al. Hybrid biomembranefunctionalized nanorobots for concurrent removal of pathogenic bacteria and toxins[J]. Sci Robot, 2018, 3(18): eaat0485.
[30]He Y, Li R, Liang J, et al. Drug targeting through platelet membranecoated nanoparticles for the treatment of rheumatoid arthritis[J]. Nano Res, 2018, 11(11): 6086-6101.
[31]Wei X, Gao J, Fang RH, et al. Nanoparticles camouflaged in platelet membrane coating as an antibody decoy for the treatment of immune thrombocytopenia[J]. Biomaterials, 2016, 111: 116-123.